高尿酸血症对老年2型糖尿病患者微血管病变的影响

doi:10.3969/j.issn.1006-6233.2025.08.015

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1159 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the effect of hyperuricemia (HUA) on microvascular disease (MVD) in elderly patients with type 2 diabetes mellitus (T2DM). Methods: 102 patients with T2DM admitted to the hospital from January 2021 to January 2024 were selected. The detection rate of HUA was statistically analyzed. The patients were divided into MVD group and non-MVD group according to the presence/absence of MVD. The incidence of HUA, general data, and biochemical indicators were compared between the two groups. Multivariate logistic regression analysis was used to screen risk factors for MVD in elderly patients with T2DM. Results: The detection rate of HUA in this study was 73.53%. There were 72 patients with MVD and 30 patients without. Univariate analysis showed that the proportions of patients with HUA and hypertension were significantly higher in the MVD group than in the non-MVD group. The inter-group differences in body mass index (BMI), course of disease and triglyceride were statistically significant (P<0.05). Multivariate logistic regression analysis showed that HUA, BMI, hypertension, and triglyceride were risk factors for MVD in elderly patients with T2DM (P<0.05). Conclusion: HUA is also one of the risk factors for MVD in elderly patients with T2DM. In addition, the relationship between BMI, hypertension, triglyceride and MVD in elderly patients with T2DM deserves clinical attention.

Key words： Type 2 diabetes mellitus Elderly Hyperuricemia Microvascular disease

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DIAO Xinchen
	WANG Sihong
	SONG Quanchao

Cite this article:

DIAO Xinchen,WANG Sihong,SONG Quanchao. Effect of Hyperuricemia on Microvascular Disease in Elderly Patients with Type 2 Diabetes Mellitus[J]. HeBei Med, 2025, 31(8): 1322-1326.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2025.08.015 OR http://www.hbyxzzs.cn/EN/Y2025/V31/I8/1322

[1] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.2型糖尿病基层诊疗指南(实践版·2019)[J].中华全科医师杂志,2019,18(9):810-818.
[2] 杨海涛,王冠,邱良贤.HbA1C联合血脂指标对老年2型糖尿病患者发生心脑血管事件的预测价值评估[J].中南医学科学杂志,2024,52(6):1003-1005.
[3] 李东霞,陈书艳,王燕,等.老年新诊断2型糖尿病病人血糖变异性与炎症因子及微血管病变关系的探讨[J].实用老年医学,2020,34(10):1068-1071.
[4] 马林通,徐晓,王佳,等.2型糖尿病微血管病变与血管内皮功能及血压的关系[J].山东医药,2023,63(4):67-69.
[5] 王华,高迎.高尿酸血症对2型糖尿病微血管病变的影响因素分析[J].中国临床医生杂志,2021,49(4):446-448.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[7] 中国微循环学会糖尿病与微循环专业委员会,中国医疗保健国际交流促进会基层卫生分会基层糖尿病学部,江苏省基层内分泌特色科室孵化联盟.基层糖尿病微血管病变筛查与防治专家共识(2021年版)[J].中国医学前沿杂志(电子版),2021,13(6):16-38.
[8] 中华医学会内分泌学分会.中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13.
[9] 申格格,周洁,付建芳,等.高尿酸血症在糖尿病周围神经病变发病机制中的研究进展[J].医学新知,2024,34(4):466-472.
[10] 黄花,徐冬冬,任建宇.2型糖尿病合并高尿酸血症青年患者代谢相关因素分析[J].中国现代医学杂志,2020,30(21):53-57.
[11] 李卓席,黄成虎,胡永梅,等.2型糖尿病合并高尿酸血症患者微血管病变研究[J].实用临床医药杂志,2022,26(21):65-69.
[12] 贺亚峰,李海滨,宋博峰.糖尿病肾病合并高尿酸血症患者的血尿酸和肾功能关系分析[J].贵州医药,2021,45(12):1905-1906.
[13] 宁光.糖尿病患者的血压控制目标:临床流行病学研究分析与相关指南的更新解读[J].诊断学理论与实践,2018,17(1):1-4.
[14] 马鸣飞,马杉杉,刘燕,等.2型糖尿病患者代谢指标达标情况和微血管并发症患病情况及后者的影响因素分析[J].中国医药,2023,18(2):224-227.
[15] 符诗,王永和,陈奕奕.2型糖尿病患者不同中医证型与其下肢动脉粥样硬化病变程度及足部微血管改变的相关性分析[J].广州中医药大学学报,2023,40(11):2697-2701.